Carvedilol for heart failure, with care
- 1 May 1996
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 347 (9010) , 1199-1201
- https://doi.org/10.1016/s0140-6736(96)90729-1
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Effects of carvedilol on cardiovascular hospitalizations in patients with chronic heart failureJournal of the American College of Cardiology, 1996
- Effect of carvedilol in severe chronic heart failureJournal of the American College of Cardiology, 1996
- Effects of Carvedilol, a Vasodilator–β-Blocker, in Patients With Congestive Heart Failure Due to Ischemic Heart DiseaseCirculation, 1995
- Effects of beta blockers on ventricular dysfunction after myocardial infarction: Tolerability and survival effectsThe American Journal of Cardiology, 1993
- Carvedilol Inhibits Vascular Smooth Muscle Cell ProliferationJournal of Cardiovascular Pharmacology, 1993
- Clinical pharmacology of carvedilol in normal volunteersClinical Pharmacology & Therapeutics, 1987
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984
- PROLONGATION OF SURVIVAL IN CONGESTIVE CARDIOMYOPATHY BY BETA-RECEPTOR BLOCKADEThe Lancet, 1979